Dr Vaishampayan on the Rationale For the SWOG-1931/PROBE Trial in Advanced RCC

Ulka Nitin Vaishampayan, MBBS, discusses the rationale for conducting the phase 3 SWOG 1931 trial in patients with advanced renal cell carcinoma.

Related Keywords

Michigan ,United States ,Ulka Nitin Vaishampayan ,University Of Michigan ,Phasei Program At Rogel Cancer Center ,International Kidney Cancer Symposium ,Phasei Program ,Rogel Cancer Center ,Kidney Cancer Symposium ,Onclive Tv ,Genitourinary Cancer ,Tircc ,Renal Cell Carcinoma ,Nct04510597 ,